A Single Infusion Could Suppress H.I.V. for Years, Study Suggests
Get the Health newsletter
Daily health & science — research, biotech, public health, the studies worth knowing. Free.
- Boston conference presented a study showing that a single infusion of a patient’s own immune cells engineered to target HIV suppressed the virus to undetectable levels in two participants, one for nearly two years.
- UCSF researchers note the therapy is years or decades from broad availability, but the data serve as proof of concept for a possible single‑shot HIV cure.
- Dr. Steve Deeks led the trial and called the results “inspiration and a potential road map” toward long‑term HIV control.
- Dr. Hans‑Peter Kiem described the achievement as “truly amazing,” despite not being involved in the study.
Why it matters: Patients might avoid daily antiretroviral drugs if a single infusion maintains HIV suppression for years, cutting lifelong drug costs and improving quality of life, while biotech firms eye a new multi‑billion‑dollar market.
Ask SkimNews
